INTERVIEWS
ATENXIA is not a mere application: it is a paradigm shift in the treatment of adhd and dyslexia, linking science, technology and empathy
For the development of this solution, GeneticAI counts with the collaboration of the Madrid Parkinson ’ S Association and UC3M
This project is under the joint invitation ISCIII-CDTI 2023 envisaged within the LOSS of health of Vanguard MRR funded